chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a medical assistant referring a patient of unknown age and gender. The patient's concurrent conditions, concomitant medication and medical history were not provided. On 11-DEC-2015 the patient was vaccinated with an expired dose of VAQTA 25/0.5 (lot# K008984, expiry date 21-OCT-2015, does and route were unspecified). No adverse effect was reported. No product quality complaint (PQC). Additional information has been requested.
achy; bit tired; This is a spontaneous report from a contactable Other Health Professional. A 43-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date as (At the age of 43-years) SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced achy and bit tired on an unspecified date. It was reported that patient Did not have headache with second dose but felt achy and a bit tired. The outcome of events was unknown. The patient provided information regarding the reported adverse event(s) with the use of the product. The patient considered the Pfizer product had a causal effect to the adverse event.  Information on the lot/batch number has been requested.  Follow-up (13May2021): Follow-up attempts completed. No further information expected.
Fever, Chills, Soreness at injection sight, in early AM 12 hr after injection. Fatigue, Fever 100 F to 101 F with chills off and on until 01/02/20 afternoon. treated with Tylenol. rest helped and fever would break with sweats. Body aches for first 24 hours after symptoms started. gaseous loose BM's. no nausea, no appetite.
Pfizer for the patient's 2nd dose  instead of Moderna. There were no other signs and symptoms noted.
Mother called 5-1-07; related child broke out in "spots" on 4-29-07. Today related he has 9 "Pox" that are crusted over, and that child is feeling "fine".
CANCER IN THEIR BODY AND NEED SURGERY; This spontaneous report received from a consumer via a company representative via social media (social media account) concerned multiple patients of an unspecified age, sex, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2. s (suspension for injection, route of admin, and batch number were not reported, expiry: unknown) dose, start therapy date were not reported, 1 total administered for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On an unspecified date, the patient experienced cancer in their body and need surgery.  It was reported that, "as a result of these COVID shots and boosters there are a lot of people we have talked to at the hospital that "surprising now have cancer" in their body and need surgery after taking these Covid shots and boosters." The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of cancer in their body and need surgery was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20221123504, 20221123543 and 20221124203. Sender's Comments: V0: 20221123551-cancer in their body and need surgery. Insufficient information is available to make a causality assessment. Therefore, this event is considered unclassifiable.
shingles in and around my right ear; Suspected Vaccination failure; shingles; pain was excruciating.; I still have trouble with my ear; nerve had been fried; felt like I had been electrocuted; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. In May 2020, 5 months after receiving Shingles vaccine and unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, pain, ear disorder, nerve damage and feeling abnormal. On an unknown date, the patient experienced herpes zoster otitis externa (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure, shingles, pain, nerve damage, feeling abnormal and herpes zoster otitis externa were unknown and the outcome of the ear disorder was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, pain, ear disorder, nerve damage, feeling abnormal and herpes zoster otitis externa to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The case was reported by patient. The age at vaccination was not reported. The received both shingle shots. Five months later, the patient experienced the shingles that wrapped around shin, up the right side of my head, in and around right ear and up the back of neck and head. The pain was excruciating.  The patient felt like he/she had been electrocuted. The physician said nerve had been fried. The patient stated that it was in May 2020. It lasted into the fall.  The patient stated that it was August 2021 and the patient still had trouble with ear.  This case was considered as suspected vaccination failure since the details regarding laboratory confirmation of shingles were not provided.
A lot of injection site pain and it continues now; This is a spontaneous report from a contactable consumer (patient). A 79-years-old female patient received BNT162B2 (BNT162B2), dose 2 via an unspecified route of administration on 09Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Historical vaccine included flu shot for painful arm. The patient experienced a lot of injection site pain and it continues now on an unspecified date. The mean duration of pain at the injection site after Dose 2 was 2.5 days (range 1 to 36 days). The action taken in response to the event for bnt162b2 was not applicable. The outcome of event was not recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Rapid heart rate per Apple Watch 130-140 fir 35 minutes approximately  Chest pressure Pounding HR
Right arm sore and achy from injection site down to finger tips. No decreased range of motion. Feels drained of energy and tired. Initial temperature was 98.5 F at 10:30 am. Temperature at 12:45 pm was 100.5 F. Also complains of a mild headache. She was given ibuprofen 400mg at 12:50. No improvement at the time this report was written.
Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028k218, 013m208 and 0276208) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Jan-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Arm soreness). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) on 19-Jan-2022 at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm soreness) outcome was unknown.            No concomitant medications were provided.   This case was linked to MOD-2022-455764, MOD-2022-455763 (Patient Link).
101°F fever (began approximately at 9:00pm 04/02/2021; ongoing as of 4:32am 04/03/2021 ) Chills Muscle and joint pain Swollen lymph nodes in neck and armpit Fatigue Injection site pain Pain while using injected arm Headache Abnormally high thirst Difficulty sleeping
Client vaccinated on 8/18.  Came back to clinic to have left forearm assessed due to raised, swollen induration and c/o pain in the arm, and nausea.  States has appt at PCP tomorrow afternoon to have it evaluated due to the pain it is causing, and the nausea.
Swelling in mouth, burning in mouth, swollen tongue, itching on lips, later rash on face, shortness of breath.
A week after the dose, I awakened with vertigo. The vertigo initial episode lasted several hours.  The symptoms happened daily for about a week. Since the initial episode the symptoms have been recurrent every few weeks.
Initial report received from a physician on 15 Oct 2010: This patient with medical history of adiposity was vaccinated with FLUVIRIN (manufacturer and batch number unknown) on an unspecified date (in Sep 2010 or Oct 2010 presumably). One week following vaccination, the patient experienced pronounced dyspnea reported as "she would become no air" for which she was apparently admitted to hospital and was presumably being treated by the reporting physician. The physician was concerned that this could be a beginning of Guillain-Barre syndrome (GBS). The physician made a diagnosis of suspected GBS. Final outcome of the events was not reported.
NUMBNESS AND TINGLING IN FACE STARTED WITHIN 24 HOURS OF VACCINATION AND LASTED APPROXIMATELY 14 DAYS
Diagnosed with osteomyelitis post vaccination of both doses; Sour taste in her mouth; This is a spontaneous report from a Pfizer sponsored program from a contactable consumer (patient). A 66-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single dose, dose 2 via an unspecified route of administration on 06Feb2021 (Batch/Lot number was not reported) as 2nd dose, single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient has been diagnosed with osteomyelitis post vaccination of both doses of the PFIZER-BIONTECH COVID-19 VACCINE. She got her last dose on 06Feb2021. She also reported a sour taste in her mouth. The patient mentioned that she allegedly read on the Pfizer website the occurrence of transverse myelitis post vaccination of the PFIZER-BIONTECH COVID-19 VACCINE. She wanted to know if osteomyelitis has also been reported. The patient had both doses of the Covid-19 Vaccine and got out of the hospital a week ago. She was in the hospital from osteomyelitis. She saw that there were side effects from the spine for the Covid vaccine and wanted to know how it happened. She was confused. She has been sitting here the past week going how the heck did this happen and what did she do. She was diagnosed with osteomyelitis and was wondering if it could be a side effect. She has an appointment with the neurosurgeon in an hour. She was told she was being transferred to a medical professional who could answer her question. Reporter seriousness for osteomyelitis was hospitalization. The outcome of the events was unknown.  Information about lot/batch number has been requested.
18/06HIVES, HOARSENESS WEDNESDAY 10/18/06 HIVES, TORSO, BENEDRILL 2 EVERY 3.5 HOURS X2 THURS. 10/19/06      "      "       "        X4 FRIDAY 10/20/06      "      "       "  EARS, ARMS X4 SAT.   10/21/06      "      "       "   "     " LEGS, LIP, HOARSENESS  X4 SUN    10/22/06     SAME AS ABOVE  X5 MON    10/23/06     BENEDRILL X1 TUE    10/24/06     NO SYMPTOMS
An expired vaccine (12/31/2021) was administered.  No adverse event has been reported by the patient.
got the first dose of the Moderna vaccine on 17Mar2021 but still has not got the second dose; pain in the chest; difficulty breathing; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (pain in the chest), DYSPNOEA (difficulty breathing) and PRODUCT DOSE OMISSION ISSUE (got the first dose of the Moderna vaccine on 17Mar2021 but still has not got the second dose) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced CHEST PAIN (pain in the chest) and DYSPNOEA (difficulty breathing). On 18-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (got the first dose of the Moderna vaccine on 17Mar2021 but still has not got the second dose). On 01-Apr-2021, CHEST PAIN (pain in the chest) and DYSPNOEA (difficulty breathing) had resolved. On 18-May-2021, PRODUCT DOSE OMISSION ISSUE (got the first dose of the Moderna vaccine on 17Mar2021 but still has not got the second dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: normal (Inconclusive) inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were provided. Patient does not take any medication regularly. No concomitant medication information was provided.
76 years old female who has a history of COPD hypertension back pain back surgeries patient is a vaccinated against the Covid 19.  Patient experiencing cough congestion shortness of breath for 2 weeks progressively getting worse with those complaints came to the emergency room last night patient was hypoxemic patient was started on oxygen chest x-ray showed bilateral pneumonia Covid test positive patient was admitted ID consultation requested patient was started on dexamethasone.  Pt requred high flow O2 , also Bipap but Pt coditione cont to deteriorate and develop multiorgan failre , Pt was intubated, condition was discussed with POA. Pt was in poor physical state secondary to other medical problems like COPD, malnutrition  and failure to thrive. POA asked for DNR status. Pt could not survive and passed away
SHARP, PERSISTENT HEADACHE, CHILLS, NAUSEA, VOMITTING
Face, neck and chest had raised, itchy rash for 3 days. The rest of my body was itchy as well, but did not have a visible rash. 1 hive on left knee area. Headache x 3 days.
After the vaccination was given the patient started to wait her 15 minutes.  After 5 minutes of waiting the patient slumped over and passed out onto the floor.  Her color was very pale and her eyes were rolling in the back of her head.  She regained consciousness but her color was still poor and we called and ambulance because she was still feeling faint.  The  EMT's immediately took her blood pressure and it was extremely low.  She acknowledged that she did not eat or drink anything at all that morning.  The EMT's recommended she go to the hospital but she refused.  After 30 minutes with emergency personnel she felt better and well enough to leave with her family member who was with her.
This spontaneous report was received from a physician and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, during the same office visit, the patient was vaccinated with 1 dose of M-M-R II with sterile diluent (MERCK) in the left thigh (dosage, lot number and expiration date were not reported) for prophylaxis; with 1 dose of influenza virus vaccine (unspecified) in the left thigh (dosage, lot number and expiration date were not reported) for prophylaxis; and 2 other unspecified vaccines (dose, route, lot number and expiration date were not reported) for prophylaxis. On an unknown date, about 4 days later, the patient got a rash at the injection sites of the M-M-R II and influenza virus vaccine (unspecified). The outcome of injection site rash was not reported. The causal relationship between the event injection site rash and the suspect therapies M-M-R II, sterile diluent (MERCK), influenza virus vaccine (unspecified) and unspecified vaccine was not provided.
I had weakness, sore arm, diarrhea, tingling in face, swelling in left arm, redness.
Febrile seizure that occurred on 4/2/14. No treatment except for Ibuprofen.
This is in follow-up to report (s) previously submitted on 02/13/2009. Information has been received from a licensed practical nurse concerning a 19 year old female patient with no known medical history; who on 20-AUG-2008 was vaccinated with a 0.5 ml second dose of GARDASIL vaccine, intramuscularly. There was no concomitant medication. The patient developed tachycardia after she received the GARDASIL vaccine. The patient sought medical attention through a cardiologist visit. Additional information has been requested. Follow up information received on 04-MAR-2009 from the licensed practical nurse, stated that the patient received the first dose GARDASIL on 19-JUN-2008 (previously reported on 20-JAN-2008) (lot # 654272/0073X) and second dose of GARDASIL on 20-AUG-2008 (lot # 654272/0073X). The patient has a follow up appointment with the physician on 14-JAN-2009 and the patient stated that she began having palpitations after she received the second of GARDASIL. The exact onset date was not reported. It was documented that the patient was experiencing tachyarrhythmia. The patient was not admitted to the hospital. The patient was seen by a cardiologist. Additional information has been requested.
Severe right axillary adenopathy (same as inj site arm) within 48 hrs of injection 3" diameter painful (7/10) initially causing moderately severe pain that felt muscular while expanding chest or inhaling. Fever up to 102.5F, lethargy, muscle pain, dyspnea, nausea, rash (look like hives)
From mailed correspondence received on 6/29/01 from reporting nurse, stated that a 12 month old pt received an IPOL and a Varivax vaccination on 6/11/01 at 10:30AM. Reportedly on 6/12/01 at 13:30, the pt was in daycare and experienced a "faint episode", was pushing toy, looked wobbly, went limp, "breathless" color of lips turned purple and his head went back. There was no foaming at the mouth. The episode lasted for a few minutes; the pt then took a breath. There were no tonic-clonic movements. The pt now has right otitis media. He reportedly, recovered from this event. No further information was provided from follow-up correspondence returned on 10/25/01.
patient came to the pharmacy and completed the intake form for the Moderna Bivalent COVID19 vaccine. The pharmacist administered the Moderna Bivalent COVID19 vaccine. The patient then informed the pharmacist that she had received the Moderna Bivalent COVID19 vaccine the week prior and she had come in today for the flu shot. The patient felt nervous but was assured that she may have amplified side effects which can be managed with Tylenol, hydration and rest. The patient called the pharmacy about 20-30 minutes later and informed the pharmacist that she checked with an infectious disease doctor and was assured the same thing. She felt fine at this point.
pt recv vax 11JUN96 & 13JUN96 pt exp 3 lesions in the inj arm that were 1/2-1/4 circular & linear vesicles, water & blood filled;also exp a sore arm;
Staff member reported being sick and in bed for 3 days.  Staff member also noted 'sporadic nose bleeds'.
arm was sore; arm was swollen; arm was red; able to taste it (the shot); bad indigestion; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (arm was sore), PERIPHERAL SWELLING (arm was swollen), ERYTHEMA (arm was red), TASTE DISORDER (able to taste it (the shot)) and DYSPEPSIA (bad indigestion) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced ARTHRALGIA (arm was sore), PERIPHERAL SWELLING (arm was swollen), ERYTHEMA (arm was red), TASTE DISORDER (able to taste it (the shot)) and DYSPEPSIA (bad indigestion). On 24-Jan-2021, TASTE DISORDER (able to taste it (the shot)) had resolved. On 27-Jan-2021, ARTHRALGIA (arm was sore), PERIPHERAL SWELLING (arm was swollen), ERYTHEMA (arm was red) and DYSPEPSIA (bad indigestion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
This spontaneous report as received from a medical assistant refers to a patient of unknown age. On 01-OCT-2013, the patient was vaccinated with a dose of PNEUMOVAX 23 lot # J006921, expiry date 09-AUG-2014. On an unknown date in 2013, the patient experienced injection site reaction that she described as soreness in her arm and warm to touch and soreness in her arm and warm to touch. No treatment was rendered for the events. The outcome of the events were reported as unknown. The patient was scheduled for a follow up appointment. This is one of the 3 reports received from the same reporter. Additional information has been requested.
Patient has a lot of fatique, vertigo. One evening couldn't make it from the car to the door. Went to sleep. Woke up feeling the same way.  Went to ER. Took Covid test, negative. Doctor took x-rays, notice blood clots, admitted for 3 days. Doctor said blood clots were a triggered by an event-Covid. His next appointment is on July 17th. Potential lifetime damage. Patient continuing to feel fatique and shortness of breath.
Shoulder injury, right 2 weeks of continuing persistent shoulder pain with forward flexion, abduction, external rotation.  No fever, chills, swelling, rash, weakness/numbness/tingling. Treating with acetaminophen and ibuprofen, shoulder movement exercises.
On 10/16/1999 pt developed a varicella rash. The pt presented to the physicians office on 10/19/1999 with a varicella like rash consisting of less than 50 lesions. Approximately one week later the pt recovered.
Swelling of groin and testicles; Swelling of groin and testicles; Pain on hands and feet; Weakness; Chills; Generalized pain; Insomnia; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Generalized pain), SWELLING (Swelling of groin and testicles) and TESTICULAR SWELLING (Swelling of groin and testicles) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported).    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced INSOMNIA (Insomnia). On 26-Mar-2021, the patient experienced PAIN (Generalized pain) (seriousness criterion medically significant), ASTHENIA (Weakness) and CHILLS (Chills). On 27-Mar-2021, the patient experienced SWELLING (Swelling of groin and testicles) (seriousness criterion medically significant), TESTICULAR SWELLING (Swelling of groin and testicles) (seriousness criterion medically significant) and PAIN IN EXTREMITY (Pain on hands and feet). At the time of the report, PAIN (Generalized pain), INSOMNIA (Insomnia), ASTHENIA (Weakness) and CHILLS (Chills) was resolving and SWELLING (Swelling of groin and testicles), TESTICULAR SWELLING (Swelling of groin and testicles) and PAIN IN EXTREMITY (Pain on hands and feet) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.